Identification of distinctive interferon gene signatures in different types of myositisIago Pinal‐Fernandez, Andrew L. Mammen, María Casal-Domínguez et al.|Neurology|2019Cited by 225
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseasesJake A. Ruddy, Julie J. Paik, Caoilfhionn M Connolly et al.|Annals of the Rheumatic Diseases|2021Cited by 138
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following <scp>Two‐Dose SARS</scp>–<scp>CoV</scp>‐2 Messenger <scp>RNA</scp> VaccinationCaoilfhionn M Connolly, Julie J. Paik, Jake A. Ruddy et al.|Arthritis & Rheumatology|2021Cited by 116
Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case SeriesCaoilfhionn M Connolly, Julie J. Paik, Brian J. Boyarsky et al.|Annals of Internal Medicine|2021Cited by 62
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case seriesCaoilfhionn M Connolly, Julie J. Paik, Teresa Po‐Yu Chiang et al.|Annals of the Rheumatic Diseases|2021Cited by 60